171 related articles for article (PubMed ID: 14617206)
21. Humoral rejection of organ allografts.
Moll S; Pascual M
Am J Transplant; 2005 Nov; 5(11):2611-8. PubMed ID: 16212619
[TBL] [Abstract][Full Text] [Related]
22. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
23. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
AlMahri A; Holgersson J; Alheim M
Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
[TBL] [Abstract][Full Text] [Related]
24. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
[TBL] [Abstract][Full Text] [Related]
25. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'.
Kim PT; Demetris AJ; O'Leary JG
Curr Opin Organ Transplant; 2016 Apr; 21(2):209-18. PubMed ID: 26918881
[TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
[TBL] [Abstract][Full Text] [Related]
27. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
[TBL] [Abstract][Full Text] [Related]
28. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
Pescovitz MD
Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
[TBL] [Abstract][Full Text] [Related]
29. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
[TBL] [Abstract][Full Text] [Related]
30. The generation and maintenance of serum alloantibody.
Clatworthy MR; Espeli M; Torpey N; Smith KG
Curr Opin Immunol; 2010 Oct; 22(5):669-81. PubMed ID: 20932734
[TBL] [Abstract][Full Text] [Related]
31. C4d deposition in cardiac allografts correlates with alloantibody.
Smith RN; Brousaides N; Grazette L; Saidman S; Semigran M; Disalvo T; Madsen J; Dec GW; Perez-Atayde AR; Collins AB
J Heart Lung Transplant; 2005 Sep; 24(9):1202-10. PubMed ID: 16143234
[TBL] [Abstract][Full Text] [Related]
32. The pathogenesis of acute allograft dysfunction in desensitized renal transplant recipients.
Singh N; Sun Q; Nadasdy T; Adams P; Dipaola NR; Pesavento T; Winters H; Satoskar A; Yu Z; Henry M; Hadley GA; Pelletier RP
Clin Transplant; 2012; 26(4):E402-11. PubMed ID: 22882695
[TBL] [Abstract][Full Text] [Related]
33. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
34. Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.
Burbach M; Suberbielle C; Brochériou I; Ridel C; Mesnard L; Dahan K; Rondeau E; Hertig A
Transplantation; 2014 Nov; 98(10):1056-9. PubMed ID: 24839895
[TBL] [Abstract][Full Text] [Related]
35. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.
Jordan SC; Vo AA; Toyoda M; Tyan D; Nast CC
Pediatr Transplant; 2005 Apr; 9(2):155-61. PubMed ID: 15787786
[TBL] [Abstract][Full Text] [Related]
36. Experience with antibody-mediated rejection in kidney allograft recipients.
Wade E; Goral S; Kearns J; Pierce E; Trofe J; Bloom R; Kamoun M
Clin Transpl; 2006; ():439-46. PubMed ID: 18365401
[TBL] [Abstract][Full Text] [Related]
37. Antibody-mediated rejection in pediatric liver transplant recipients.
Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
[TBL] [Abstract][Full Text] [Related]
38. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
39. Donor-specific antibodies in allograft rejection: clinical and experimental data.
Rifle G; Mousson C; Martin L; Guignier F; Hajji K
Transplantation; 2005 Feb; 79(3 Suppl):S14-8. PubMed ID: 15699738
[TBL] [Abstract][Full Text] [Related]
40. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
